Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials - Viney, N J; van Capelleveen, J C; Geary, R S (Lancet, 2016)